Daniel MacLachlan - 01 Nov 2024 Form 4 Insider Report for Red Violet, Inc. (RDVT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Nov 2024, 18:47:12 UTC
Prior SEC filing
01 Oct 2024
Next SEC filing
25 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel MacLachlan

Key filing fact

Daniel MacLachlan filed Form 4 for Red Violet, Inc. (RDVT) on 05 Nov 2024.

Key facts

  • This page summarizes Daniel MacLachlan's Form 4 filing for Red Violet, Inc. (RDVT).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Nov 2024, 18:47.

Change

  • Previous filing in this sequence was filed on 01 Oct 2024.
  • Current net transaction value: -$200,543.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RDVT transaction

Common Stock

Award

Transaction value
Shares
+13,333
Change %
+3.6%
Price
Shares after
384,751
Date
01 Nov 2024
Ownership
Direct
Footnotes
F1, F2, F3
RDVT transaction

Common Stock

Tax liability

Transaction value
$200,543
Shares
-6,667
Change %
-1.7%
Price
$30.08
Shares after
378,084
Date
01 Nov 2024
Ownership
Direct
Footnotes
F2, F3, F4
RDVT transaction

Common Stock

Award

Transaction value
Shares
+31,500
Change %
+8.3%
Price
Shares after
409,584
Date
04 Nov 2024
Ownership
Direct
Footnotes
F2, F3, F5
RDVT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
466
Date
01 Nov 2024
Ownership
Held by IRA
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the second vesting of 13,333 restricted stock units (RSUs) of the grant originally approved by the Company's Compensation Committee on October 12, 2022.

Footnote F2

Includes 13,333 RSUs originally granted on October 12, 2022, convertible into common stock of the issuer on a one-for-one basis, which vests on November 1, 2025, subject to accelerated vesting under certain conditions.

Footnote F3

Includes 40,000 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2024, December 1, 2025, and December 1, 2026, subject to accelerated vesting under certain circumstances.

Footnote F4

Represents the disposition to issuer for tax obligations upon the vesting of RSUs.

Footnote F5

On November 4, 2024, the reporting person received a grant of 31,500 RSUs convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of November 1, 2025, November 1, 2026, and November 1, 2027, subject to accelerated vesting under certain circumstances.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .